“Regeneron set Eylea’s price well beyond what the market would otherwise bear,” the complaint states, and left Medicare plan sponsors like United “to foot the large majority of the inflated bill.”
This content is for Westfair Online members only. Please Sign in / Join to view this content. Become a member by Registering Here.
